Диссертация (1140306), страница 27
Текст из файла (страница 27)
‒ 2004. ‒ Vol. 86-A, № 11. ‒ P. 2567.202.Bernuzzi G., Petraglia F., Pedrini M.F. et al. Use of platelet-rich plasma in thecare of sports injuries: our experience with ultrasound-guided injection // BloodTransfus. ‒ 2014. ‒ Vol. 12 Suppl 1. ‒ P. s229-234.203.Berend K.R., Lombardi A.V. Jr., Adams J.B. Total knee arthroplasty inpatients with greater than 20 degrees flexion contracture. // Clin. Orthop. Relat.Res.
– 2006; 452: 83–7.204.Berg E.E., Ciullo J.V. // Arthroscopy. - 1993. - Vol.9, № 5. - P.576-9.205.Berger R.A., Kusuma S.K., Sanders S.A., Thill E.S., Sporer S.M. Thefeasibility and perioperative complications of outpatient knee arthroplasty. //Clin. Orthop. Relat. Res. – 2009; 467(6): 1443–9.206.Bijlsma J.W., Berenbaum F., Lafeber F.P. Osteoarthritis: an update withrelevance for clinical practice // Lancet. ‒ 2011. ‒ Vol. 377, № 9783. ‒ P. 21152126.177207.Bittencourt PB, Neto OAL, Arenas GCF.
The Use of Platelet-Rich PlasmaRegenerative Medicine: Sports Medicine, Orthopedic, and Recovery ofMusculoskeletal Injuries, Springer. 2014; 147. DOI: 10.1007/978-3-642-401176.208.Bohensky M.A. et al. Trends in elective knee arthroscopies in a populationbased cohort, 2000-2009. // Med. J.
Aust. – 2012; 197: 399–403.209.Bondeson J. Are we moving in the right direction with osteoarthritis drugdiscovery? // Expert Opin Ther Targets. ‒ 2011. ‒ Vol. 15, № 12. ‒ P.13551368.210.Bohensky M.A., Ademi Z., deSteiger R., Liew D., Sundararajan V., BucknillA., et al. Quantifying the excess cost and resource utilization for patients withcomplications associated with elective knee arthroscopy: a retrospective cohortstudy. // Knee.
– 2014; 21: 491–6.211.Borus T., Thornhill T. Unicompartmental knee arthroplasty. // J. Am. Acad.Orthop. Surg. – 2008; 16(1): 9–18.212.Brandt, K.D. Diagnosis and nonsurgical management of osteoarthrosis //Professional Communication. - 2001. - 304 p.213.Brandt K.D., Mazzuca S.A., Conrozier T., et al. Which is the best radiographicprotocol for a clinical trial of a structure-modifying drug in patients with kneeosteoarthritis? // J.
Rheumatol. – 2002; 29(6): 1308–20.214.Braun H.J., Kim H.J., Chu C.R. et al. The effect of platelet-rich plasmaformulations and blood products on human synoviocytes: implications forintraarticular injury and therapy // Am J Sports Med. ‒ 2014. ‒ Vol. 42, № 5. ‒ P.1204-1210.215.Breivik H., Borchgrevink C., Allen S.M. et al. Assessment of pain / Br.
J.Anaesth. – 2008; 101(1): 17–24.216.Briggs K.K., Matheny L.M., Steadman J.R. Can Hylan G-F 20 withcorticosteroid meet the expectations of osteoarthritis patients? // Am J Orthop(Belle Mead NJ). ‒ 2012. ‒ Vol. 41, № 7. ‒ P. 311-315.178217.Brittberg M., Gersoff W.K. Cartilage surgery: an operative manual: Saunders;1 Har/Psc edition. - 2010. - 320 p.218.Brittberg M, Winalski C S. Evaluation of cartilage injuries and repair. // J.Bone Joint Surg.
Am. – 2003; 85-A Suppl. 2: 58–69.219.Brouwer R.W., Jakma T.S., Verhagen A.P., Verhaar J.A., Bierma-ZeinstraS.M. Braces and orthoses for treating osteoarthritis of the knee. // ChocraneDatabase Syst. Rev. – 2005; 1: CD004020.220.Buckland-Wright C. Which radiographic techniques should we use for researchand clinical practice? // Best Pract. Res. Clin. Rheumatol. – 2006; 20: 39–55.221.Brumby S.A., Thornhill T.S. Unicompartmental Osteoarthritis of the Knee. In:Laskin RS, ed. Controversies in Total Knee Replacement. Oxford, UK: OxfordUniversity Press; 2001: 285–312.222.Bruyère O., Cooper C., Pelletier J.P., et al.
An algorithm recommendation for themanagement of knee osteoarthritis in Europe and internationally: a report from atask force of the European Society for Clinical and Economic Aspects ofOsteoporosis and Osteoarthritis (ESCEO). // Semin Arthritis Rheum. – 2014;44(3): 253–63.223.Burleigh A., Chanalaris A., Gardiner M.D. et al. Joint immobilization preventsmurine osteoarthritis and reveals the highly mechanosensitive nature of proteaseexpression in vivo // Arthritis Rheum.
‒ 2012. ‒ Vol. 64, № 7. ‒ P. 2278-2288.224.Cain, E.L. Clancy W.G. Treatment algorithm for osteochondral injuries of theknee // Clin. Sports Med. - 2007. - № 20. - P. 321-342.225.Çalış H.T., Sutbeyaz S.T., Guler E. et al. Efficacy of intra-articular autologousplatelet rich plasma application in knee osteoarthritis // Arch. Rheumatol. 2015. – Vol.30. – P.198–205.226.Campbell K.A., Saltzman B.M., Mascarenhas R. et al. Does IntraarticularPlatelet-Rich Plasma Injection Provide Clinically Superior Outcomes ComparedWith Other Therapies in the Treatment of Knee Osteoarthritis? A SystematicReview of Overlapping Meta-analyses // Arthroscopy. ‒ Epub.
2015. May 29.179227.Catani F., Digennaro V., Ensini A., Leardini A., Giannini S. Navigationassisted total knee arthroplasty in knees with osteoarthritis due to extra-articulardeformity. // Knee Surg. Sports Traumatol. Arthrosc. – 2012; 20: 546–51.228.Cavallo C., Filardo G., Mariani E. et al.
Comparison of platelet-rich plasmaformulations for cartilage healing: an in vitro study // J Bone Joint Surg Am. ‒2014. ‒ Vol. 96, № 5. ‒ P. 423-429.229.Cerejo R., Dunlop D.D., Cahue S., Channin D., Song J., Sharma L. Theinfluence of alignment on risk of knee osteoarthritis progression according tobaseline stage of disease.
// Arthritis Rheum. – 2002; 46(10): 2632–6.230.Cervelli V., Lucarini L., Spallone D. et al. Use of platelet-rich plasma andhyaluronic acid in the loss of substance with bone exposure // Adv Skin WoundCare. ‒ 2011. ‒ Vol. 24, № 4. ‒ P. 176-181.231.Cerza F., Carni S., Carcangiu A. et al.
Comparison between hyaluronic acidand platelet-rich plasma, intra-articular infiltration in the treatment ofgonarthrosis // Am J Sports Med. ‒ 2012. ‒ Vol. 40, № 12. ‒ P. 2822-2827.232.Chang K.V., Hung C.Y., Aliwarga F. et al. Comparative effectiveness ofplatelet-rich plasma injections for treating knee joint cartilage degenerativepathology: a systematic review and meta-analysis // Arch Phys Med Rehabil. ‒2014. ‒ Vol. 95, № 3. ‒ P.
562-575.233.Chatterjee M., Huang Z., Zhang W. et al. Distinct platelet packaging, release,and surface expression of proangiogenic and antiangiogenic factors on differentplatelet stimuli // Blood. ‒ 2011. ‒ Vol. 117, № 14. ‒ P. 3907-3911.234.Chen W.H., Lo W.C., Hsu W.C. et al. Synergistic anabolic actions ofhyaluronic acid and platelet-rich plasma on cartilage regeneration inosteoarthritis therapy // Biomaterials.
‒ 2014. ‒ Vol. 35, № 36. ‒ P. 9599-9607.235.Chien C.S., Ho H.O., Liang Y.C. et al. Incorporation of exudates of humanplatelet-rich fibrin gel in biodegradable fibrin scaffolds for tissue engineering ofcartilage // J Biomed Mater Res B Appl Biomater. ‒ 2012. ‒ Vol. 100, № 4. ‒ P.948-55.180236.Chost, P. Smith M.
Osteoarthritis, genetic and molecular mechanisms //Biogerontology. - 2002. - № 3. - P. 85-88.237.Christensen R., Bartels E.M., Astrup A., Bliddal H. Effect of weight reductionin obese patients diagnosed with knee osteoarthritis: a systematic review andmeta-analysis.
// Ann. Rheum. Dis. – 2007; 66 (4): 433–9.238.Cicuttini, F.M. Medical management of osteoarthritis of the knee and hipjoints // Med. J. Aust. 2004. - № 180 (5). - P. 232-236.239.Cicuttini F.M., Specfor T.D. Osteoarthritis in the aged. Epidemiological issuesan optimal managcment / ZDrugs Aging.
– 1995; 6(5): 409–20.240.Civinini R., Nistri L., Martini C. et al. Growth factors in the treatment of earlyosteoarthritis // Clin Cases Miner Bone Metab. ‒ 2013. ‒ Vol. 10, № 1. ‒ P. 26-9.241.Cleland J.A., Koppenhaver S. Netter’s orthopedics clinical examination. 2nded. Philadelphia: Saunders; 2011.242.Coggon D., Croft P., Kellingray S., et al. Occupational physical activities andosteoarthritis of the knee.
// Arthritis Rheum. – 2000; 43(7): 1443–9.243.Cole B.J., Karas V., Hussey K. et al. Hyaluronic acid versus platelet-richplasma: a prospective, double-blind randomized controlled trial comparingclinical outcomes and effects on intra-articular biology for the treatment ofKnee osteoarthritis // Am.J.Sport Med – 2017 – 45(2) – p.339-346244.Colen S., van den Bekerom M.P., Mulier M. et al. Hyaluronic acid in thetreatment of knee osteoarthritis: a systematic review and meta-analysis withemphasis on the efficacy of different products //BioDrugs ‒ 2012 ‒ Vol.
26, № 4 ‒P.257-68.245.Conaghan P.G., Felson D.T. Structural associations of osteoarthritis pain: lessonsfrom magnetic resonance imaging. Novartis Found Symp. – 2004; 260: 191–279.246.Cram P., Lu X., Kates S.L., Singh J.A., Li Y., Wolf B.R. Total kneearthroplasty volume, utilization, and outcomes among Medicare beneficiaries,1991–2010. // JAMA.
– 2012; 308(12): 1227–36.181247.Crescibene A. et al. Infiltration of Autologous Growth Factors in ChronicTendinopathies. Journal of blood transfusion 2015:924380. MSK RegenFibrinPolymer 2, Regen THT http://www.ncbi.nlm.nih.gov/pubmed/26171277248.Cugat R. Lecture Foreword I. In: Lana JF (ed), Platelet-Rich PlasmaRegenerative Medicine: Sports Medicine, Orthopedic, And Recovery ofMusculoskeletal Injuries, Springer.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
